Summit Trail Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98M Buy
6,758
+2,779
+70% +$913K 0.03% 533
2025
Q4
$1.39M Sell
3,979
-1,400
-26% -$473K 0.02% 636
2025
Q3
$1.74M Buy
5,379
+638
+13% +$198K 0.02% 520
2025
Q2
$1.84M Buy
+4,741
New +$1.91M 0.03% 288
2024
Q4
Sell
-3,545
Closed -$1.84M 508
2024
Q3
$1.84M Buy
3,545
+469
+15% +$251K 0.05% 168
2024
Q2
$1.67M Buy
3,076
+302
+11% +$160K 0.04% 163
2024
Q1
$1.44M Buy
2,774
+810
+41% +$403K 0.04% 169
2023
Q4
$926K Sell
1,964
-58
-3% -$26.8K 0.03% 191
2023
Q3
$880K Sell
2,022
-460
-19% -$209K 0.03% 184
2023
Q2
$1.1M Buy
2,482
+1,135
+84% +$524K 0.04% 156
2023
Q1
$619K Buy
1,347
+472
+54% +$225K 0.02% 190
2022
Q4
$449K Buy
875
+153
+21% +$77.7K 0.02% 200
2022
Q3
$328K Sell
722
-24
-3% -$11.5K 0.02% 236
2022
Q2
$360K Buy
+746
New +$369K 0.02% 235
2019
Q1
Sell
-2,270
Closed -$596K 108
2018
Q4
$596K Sell
2,270
-1,800
-44% -$495K 0.21% 52
2018
Q3
$1.11M Buy
+4,070
New +$1.06M 0.25% 54
2018
Q2
Sell
-4,209
Closed -$246K 534
2018
Q1
$246K Buy
4,209
+3,075
+271% +$722K 0.04% 322
2017
Q4
$280K Buy
+1,134
New +$242K 0.04% 336

Other funds holding ELV

Summit Trail Advisors's ELV Position: Q1 2026 in Review

Summit Trail Advisors increased its Elevance Health (ELV) stake by 70% in Q1 2026, buying an estimated $913K and bringing the position to 6,758 shares worth $1.98M. The position accounts for 0.03% of the portfolio, ranked #533.

Summit Trail Advisors first reported a position in ELV in Q4 2017 and has held it in 18 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Summit Trail Advisors held 6,758 shares of Elevance Health worth $1.98M as of Q1 2026.
  • Summit Trail Advisors bought 2,779 Elevance Health shares in Q1 2026, an estimated $913K.
  • Elevance Health made up 0.03% of Summit Trail Advisors's portfolio in Q1 2026, its #533 holding.
  • Summit Trail Advisors first reported a position in Elevance Health in Q4 2017 and has held it in 18 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.